These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8154331)

  • 1. Synthetic thrombin inhibitors as anticoagulants pharmacological aspects.
    Markwardt F; Hauptmann J
    Adv Exp Med Biol; 1993; 340():143-71. PubMed ID: 8154331
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic low-molecular weight thrombin inhibitors: the ideal antithrombotic drug? An introduction.
    Stürzebecher J; Meier J
    J Enzyme Inhib; 1995; 9(1):1-2. PubMed ID: 8568561
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin active site inhibitors.
    Das J; Kimball SD
    Bioorg Med Chem; 1995 Aug; 3(8):999-1007. PubMed ID: 7582987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Research Progress of Direct Thrombin Inhibitors.
    Sun ZG; Yang-Liu ; Zhang JM; Cui SC; Zhang ZG; Zhu HL
    Mini Rev Med Chem; 2020; 20(16):1574-1585. PubMed ID: 31644402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.
    Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.
    Endreas W; Brüßler J; Vornicescu D; Keusgen M; Bakowsky U; Steinmetzer T
    ChemMedChem; 2016 Feb; 11(3):340-9. PubMed ID: 26662675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin inhibitors as antithrombotic agents: the importance of rapid inhibition.
    Stone SR; Tapparelli C
    J Enzyme Inhib; 1995; 9(1):3-15. PubMed ID: 8568565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
    Gardell SJ; Sanderson PE
    Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the anticoagulant activities of thrombin inhibitors as assessed by thromboelastographic analysis.
    Callas D; Iqbal O; Fareed J
    Semin Thromb Hemost; 1995; 21 Suppl 4():76-9. PubMed ID: 8747693
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombin inhibitors based on ketone derivatives of arginine and lysine.
    Jones DM; Atrash B; Ryder H; Teger-Nilsson AC; Gyzander E; Szelke M
    J Enzyme Inhib; 1995; 9(1):43-60. PubMed ID: 8568566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development.
    Fareed J; Callas D; Hoppensteadt DA; Walenga JM; Bick RL
    Med Clin North Am; 1998 May; 82(3):569-86. PubMed ID: 9646780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector.
    Figueiredo AC; de Sanctis D; Gutiérrez-Gallego R; Cereija TB; Macedo-Ribeiro S; Fuentes-Prior P; Pereira PJ
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3649-58. PubMed ID: 23223529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis.
    Iwanaga S; Okada M; Isawa H; Morita A; Yuda M; Chinzei Y
    Eur J Biochem; 2003 May; 270(9):1926-34. PubMed ID: 12709051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct thrombin inhibitors.
    Maffrand JP
    Nouv Rev Fr Hematol (1978); 1992; 34(6):405-19. PubMed ID: 1300540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors.
    Li ML; Ren YJ; Dong MH; Ren WX
    Eur J Med Chem; 2015; 96():122-38. PubMed ID: 25874337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity.
    De Nanteuil G; Gloanec P; Lila C; Portevin B; Boudon A; Rupin A; Verbeuren TJ
    Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and comparison of tripeptidylfluoroalkane thrombin inhibitors.
    Neises B; Broersma RJ; Tarnus C; Piriou F; Remy JM; Lintz C; Heminger EF; Kutcher LW
    Bioorg Med Chem; 1995 Aug; 3(8):1049-61. PubMed ID: 7582979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic [5,5] trans-fused indane lactones as inhibitors of thrombin.
    Pass M; Bolton RE; Coote SJ; Finch H; Hindley S; Lowdon A; McDonald E; McLaren J; Owen M; Pegg NA; Mooney CJ; Tang CM; Parry S; Patel C
    Bioorg Med Chem Lett; 1999 Feb; 9(3):431-6. PubMed ID: 10091697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From natural to synthetic multisite thrombin inhibitors.
    Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V
    Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.